E

Ensoma

91 employees

Ensomaa is a genomic medicine company that develops on one-time in vivo treatments for immuno-oncology and other therapeutic applications.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Genetics
Medical
Life Science

Date founded

2019

Funding rounds raised

Total raised

$85M

from 17 investors over 17 rounds

E

Ensoma raised $50M on May 16, 2023

Investors: Delos Capital, Bioluminescence Ventures and -

E

Ensoma raised $85M on January 5, 2023

Investors: Qatar Investment Authority, Mirae Asset MAPS Global Investments Co., Ltd, fred hutch, Viking Global Investors, Takeda UK Limited, F-Prime Capital Partners, Catalio Capital Management, - and Solasta Ventures

E

Ensoma raised $70M on February 11, 2021

Investors: 5AM Ventures, F-Prime Capital Partners, Takeda UK Limited, Viking Global Investors and RIT CAPITAL PARTNERS PLC

FAQ